BCAB vs EW · $5.9M cap vs P/E 47, rev $1.39B
Bioatla Inc (BCAB) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
Bioatla Inc (BCAB) is a biotechnology company listed on NASDAQ.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported BCAB revenue for 2023-09-30 was $0. Net income was -$33.3M. BCAB currently screens at market cap $5.9M.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
BCAB currently screens at market cap $5.9M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the BCAB and EW stock pages for the full models.
Not investment advice.